-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: The mechanism of rheumatoid arthritis (RA) pathogenesis induction is unclear
Recent studies have shown that mucosal surfaces play an important role in the early development of RA, especially in ACPA-positive disease
The production of mucosal antibodies mainly involves the extracellular transport of immunoglobulin (Ig) A through the polyIg receptor (pIgR) located on the basolateral surface of epithelial cells
Methods: Three groups of patients were studied: (1) ACPA-positive patients with musculoskeletal pain but not arthritis; (2) patients with recent onset rheumatoid arthritis (RA); (3) previous rheumatoid arthritis ( RA) patients
Results: The serum levels of TsigA and TSIgM in early RA patients and high-risk RA patients were higher than those in healthy controls (P<0.
The serum levels of TsigA and TSIgM in patients with early RA and high-risk RA were higher than those in healthy controls.
Circulating secretory immunoglobulins were elevated both before and during the onset of RA
Extramucosal formation and prognostic value of secretory antibodies in rheumatoid
arthritis